World News: 16:00 GMT Monday 28th July 2014. [Quark Pharmaceuticals, Inc. USA. via Globe Newswire via SPi World News]
SAN FRANCISCO July 28 2014 GLOBE NEWSWIRE -- Today Quark Pharmaceuticals Incdata from a randomized double-blinded placebo-controlled multicenter Phase II clinical trial QRK006B of a synthetic chemically modified siR NA acti...
Globe Newswire: 16:00 GMT Monday 28th July 2014
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2020. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.